Document is current
Any future updates will be listed below
-
Authors
Hompesch, Marcus https://orcid.org/0000-0001-5867-2131
Kang, Jahoon
Han, OakPil
Trautmann, Michael E
Sorli, Christopher H
Ogbaa, Ike
Stewart, John
Morrow, Linda
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02059564 at ClinicalTrials.govnct02059564 at ClinicalTrials.govDocuments that mention this clinical trial
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study
https://doi.org/10.1136/bmjdrc-2021-002208
nct02059564 at ClinicalTrials.govDocuments that mention this clinical trial
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study
https://doi.org/10.1136/bmjdrc-2021-002208
Documents that mention this clinical trial
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study
https://doi.org/10.1136/bmjdrc-2021-002208
-
Funding
Funding for this research was provided by:
Sanofi (N/A)
Hanmi Pharmaceutical (N/A)
- License Information
